Michael Hoff is a Miami, Florida based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Michael Hoff is 29394 for Ophthalmology in Florida. Michael Hoff is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Michael Hoff speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
8955 Sw 87th Court, Miami, Florida, 33176
Phone:
305-274-1920
Fax:
305-274-3804
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1477564169
NPI Enumeration Date:
10 Aug, 2006
NPI Last Update On:
31 Jan, 2019
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Hoff are as mentioned below.
License Number
Specialization
State
Status
29394
Ophthalmology
Florida
Primary
0949066
Ophthalmology
Florida
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8955 Sw 87th Court, Miami, Florida
Zip:
33176
Phone Number:
305-274-1920
Fax Number:
305-274-3804
Patients can reach Michael Hoff at 8955 Sw 87th Court, Miami, Florida or can call to book an appointment on 305-274-1920. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.